Skip to main content

David J. Katzoff

Equibles does not estimate personal net worth.

Get an email with a short summary when Alzamend Neuro, Inc. publishes a filing, an earnings call transcript or a press release.

Get ALZN alerts

About David J. Katzoff

David J. Katzoff is recorded as CFO at Alzamend Neuro, Inc. (ALZN). The newest filing on record that lists David J. Katzoff as CFO at Alzamend Neuro, Inc. (ALZN) is dated March 31, 2023. Alzamend Neuro, Inc. reported in an 8-K filed August 5, 2022 that David J. Katzoff was appointed Chief Financial Officer, effective August 5, 2022. The proxy statement of Alzamend Neuro, Inc. reports total compensation of $150,000 for David J. Katzoff in fiscal 2025, including a base salary of $150,000. Disclosed compensation is on record for 3 fiscal years. Alzamend Neuro, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Alzamend Neuro, Inc. includes Stephan S. Jackman (CEO) and Milton C. Ault, III (Board Member).

“On August 5, 2022, the Company appointed David J. Katzoff, who has been serving as the Company's Chief Operating Officer, as its new Chief Financial Officer.”
Alzamend Neuro, Inc. Form 8-K, filed August 5, 2022 · Read the filing

Affiliation history

Company network

Leadership on record at Alzamend Neuro, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Alzamend Neuro, Inc. (ALZN) $150,000 $150,000
2024 Alzamend Neuro, Inc. (ALZN) $150,000 $150,000
2023 Alzamend Neuro, Inc. (ALZN) $116,667 $116,667

Recent activity